Brown University - Product Pipeline Review - Q4 2010

GlobalData, December 2010, Pages: 54

Brown University – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Brown University – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Brown University.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Brown University with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Brown University’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.

Reasons to buy

- Identify new drug targets and therapeutic classes in Brown University’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate Brown University’s position with total access to a detailed information on its therapeutic products development.
- Assess the growth potential of Brown University in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with Brown University.
- Avoid Intellectual Property Rights related issues.

List of Tables
List of Figures
Brown University Snapshot
Brown University Overview
Key Information
Key Facts
Brown University – Research and Development Overview
Key Therapeutic Areas
Brown University – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Brown University – Pipeline Products Glance
Brown University Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Brown University – Drug Profiles
Amifostine + Paclitaxel
Product Description
Mechanism of Action
R&D Progress
Baclofen
Product Description
Mechanism of Action
R&D Progress
Carboplatin + Abraxane + Trastuzumab
Product Description
Mechanism of Action
R&D Progress
Cetuximab + Paclitaxel + Carboplatin + Radiation therapy
Product Description
Mechanism of Action
R&D Progress
CT-2103 + Radiation theraphy + Temozolomide
Product Description
Mechanism of Action
R&D Progress
Decitabine + Cytarabine + Granulocyte Colony-Stimulating Factor
Product Description
Mechanism of Action
R&D Progress
filgrastim + pegylated liposomal doxorubicin hydrochloride
Product Description
Mechanism of Action
R&D Progress
Gemcitabine + Capecitabine + Avastin
Product Description
Mechanism of Action
R&D Progress
Herceptin + Gemcitabine Hydrochloride
Product Description
Mechanism of Action
R&D Progress
Ixabepilone
Product Description
Mechanism of Action
R&D Progress
Lapatinib + Gemcitabine
Product Description
Mechanism of Action
R&D Progress
Lenalidomide
Product Description
Mechanism of Action
R&D Progress
Lenalidomide for Hepatocellular Carcinoma (Brown University)
Product Description
Mechanism of Action
R&D Progress
Lenalidomide for Hepatocellular Carcinoma (Brown University)_
Product Description
Mechanism of Action
R&D Progress
Ofatumumab + Bortezomib
Product Description
Mechanism of Action
R&D Progress
Paclitaxel Poliglumex + Cisplatin + Radiation Theraphy
Product Description
Mechanism of Action
R&D Progress
Paclitaxel Poliglumex + Cisplatin + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Panitumumab + Bevacizumab
Product Description
Mechanism of Action
R&D Progress
Topiramate
Product Description
Mechanism of Action
R&D Progress
Afinitor + Cisplatin + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Dasatinib + (Carboplatin + Paclitaxel + Radiation therapy)
Product Description
Mechanism of Action
R&D Progress
Dasatinib + Radiation therapy
Product Description
Mechanism of Action
R&D Progress
GW572016 + Gemcitabine + Oxaliplatin
Product Description
Mechanism of Action
R&D Progress
Oxaliplatin
Product Description
Mechanism of Action
R&D Progress
Paclitaxel poliglumex + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Brown University – Pipeline Analysis
Brown University – Pipeline Products by Therapeutic Class
Brown University Pipeline Products By Target
Brown University – Pipeline Products by Route of Administration
Brown University – Pipeline Products by Molecule Type
Brown University - Dormant Projects
Brown University – Locations And Subsidiaries
Head Office
Financial Deals Landscape
Brown University, Deals Summary, 2004 to 2010
Brown University Detailed Deal Summary
Cyberkinetics And Brown University Signed A Licensing Agreement
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Charter Schools - Global Outlook
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Redesigning the Public Library Building
• International Military and Government Helicopter Survey
• Sports and Fitness Nutrition - Global Strategic Business Report
• Best Practices in Student Retention, 2012 Edition
• Information Literacy Efforts Benchmarks, 2013 Edition